UroCuff makes it easier to assess bladder function in patients with BPH
The test can help clinician determine whether a second procedure would be of benefit to a patient.
What can you do about rising medical record review requests?
Physician involvement in responses to payer audits is crucial.
A tale of 2 lymph node dissections for prostate cancer
"Three decades into prostate-specific antigen screening–detected prostate cancer, the prognostic and therapeutic impacts of various types of pelvic lymph node dissection remain unclear," writes Badar M. Mian, MD.
Urology malpractice consult: Discovery phase could hold key to case
Any aha! moments usually come before trial begins.
Meta-analysis generates surprising insights on postureteroscopy urosepsis
Review of nearly 5600 patients found a 5% pooled incidence of postoperative urosepsis.
Rucaparib plus enzalutamide shows early promise in mCRPC
A phase 3 trial has already been launched to build on these early results with the combination of the PARP inhibitor and androgen receptor inhibitor.
Urinary incontinence prevalence is higher in women with diabetes
Odds of having UI were 56% higher in women with vs women without diabetes.
PSMA theranostic 177Lu-PSMA-617 approaches prime time in mCRPC
The PSMA-targeted radiopharmaceutical 177Lu-PSMA-617 is poised to become one of the first PSMA theranostics approved by the FDA.
Study highlights negative mental health impact of Peyronie disease
Depression appears to be common in patients, retrospective data indicate.
Efficacy of drug-coated balloon catheter for BPH sustained at 1-year follow-up
The Optilume drug-coated balloon catheter system is used to treat patients with lower urinary tract symptoms related to benign prostatic hyperplasia.
Pivotal OAB data published for eCoin tibial neurostimulator
Ninety-eight percent of the study population was female.
New partnership launches novel test for hereditary prostate cancer risk
Using a blood or saliva sample, ProstateNow employs a 3-pronged approach for assessing risk.
Radium-223 in mCRPC: Where are we at in 2021?
Scott T. Tagawa, MD, explained the latest developments with the radiopharmaceutical radium-223 at the 2021 New York GU 14th Annual Interdisciplinary Prostate Cancer Congress®.
2 Clarke Drive Cranbury, NJ 08512